Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 16,005,498 | $288,419,074 | -8% | 4.69% |
| 2. | Slate Path Capital David Greenspan | 13,668,233 | $246,301,559 | -33% | 3.79% |
| 3. | Millennium Management Israel Englander | 11,813,229 | $212,874,387 | -3% | 0.1% |
| 4. | Point State Capital Zach Schreiber | 9,758,344 | $175,845,359 | +7% | 3.19% |
| 5. | Glenview Capital Larry Robbins | 8,456,324 | $152,382,958 | -8% | 2.94% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | Director | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | Director | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | Officer | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | Director | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | Director | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.87 | 19,388 | 44,104 | 2024-11-20 | Filing | ||
| $17.30 | 98,943 | 0 | 2024-08-12 | Filing | ||
| $17.28 | 4,065 | 8,848 | 2024-08-09 | Filing | ||
| $17.38 | 45,060 | 0 | 2024-08-09 | Filing | ||
| $17.25 | 24,537 | 45,060 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,664,861 | $434,981,150 | 0.01% | |
| 2. | 40,327,407 | $421,018,130 | 27.96% | |
| 3. | 34,383,192 | $404,315,484 | 6.68% | |
| 4. | 34,457,656 | $359,737,929 | 17.31% | |
| 5. | 28,128,744 | $293,664,087 | 2.47% |
News See All
Jim Cramer Just Discussed These 13 Stocks
As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is wondering what 2025 will hold for markets.
12 Best Stocks Under $25 To Invest In Right Now
As reported by NPR, the Dow Jones Industrial Average soared to a record high, and so did the Nasdaq and the S&P 500, after Donald Trump’s victory in the 2024 presidential election.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript November 6, 2024Teva Pharmaceutical Industries Limited misses on earnings expectations.
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
8 Best Stocks Under $50 To Invest In Now
As we navigate through 2024, the economic landscape presents a mix of challenges and opportunities for investors.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript July 31, 2024Teva Pharmaceutical Industries Limited beats earnings expectations.
10 Best Robinhood Stocks Under $20
The market reacted favorably after the Federal Reserve’s June 11-12 meeting. The broader market marked record closes.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51.
Billionaire Hedge Funds
